Literature DB >> 8406874

Cytokine profiles associated with induction of the anticryptococcal cell-mediated immune response.

J W Murphy1.   

Abstract

Previous studies with a murine model have shown that immunization with cryptococcal culture filtrate antigen (CneF) emulsified in complete Freund adjuvant (CFA) induces two populations of anticryptococcal reactive CD4+ T cells. One population (TDH cells) transfers anticryptococcal delayed-type hypersensitivity (DTH), and the other population (Tamp cells) amplifies the anticryptococcal DTH response of given to recipient mice at the time of immunization of the recipient. Treatment of mice with cyclosporin A (CsA) ablates the induction of Tamp cells but not TDH cells. The present study focused on assessing the cytokines produced by spleen cells taken from CsA-treated and control (solvent-treated) mice at days 1, 2, 4, and 6 after immunization. Supernatants from the spleen cells cultured in vitro for 24 or 48 h in medium alone or with CneF, concanavalin A, or phorbol 12-myristate 13-acetate plus calcium ionophore were assessed for the presence of interleukin-2 (IL-2), gamma interferon (IFN-gamma), IL-4, IL-5, and tumor necrosis factor. Spleen cells from CneF-CFA-treated mice produced IL-2 and IFN-gamma, but not IL-4 or IL-5, constitutively and in response to CneF, indicating that CneF-CFA induces a Th1 response. Tumor necrosis factor was not produced. Anticryptococcal TDH cells developed in spleens in which there were low levels of IFN-gamma and IL-2 (CsA-treated, immunized mice), whereas anticryptococcal Tamp cells along with TDH cells matured in spleens in which production of IFN-gamma and IL-2 was high (solvent-treated, immunized mice). The data also suggest that IL-2 and IFN-gamma produced by Tamp cells early after adoptive transfer are influential in the development of the amplified anticryptococcal DTH response that has been observed in Tamp cell-recipient mice.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8406874      PMCID: PMC281230          DOI: 10.1128/iai.61.11.4750-4759.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2.

Authors:  C D Gimmi; G J Freeman; J G Gribben; K Sugita; A S Freedman; C Morimoto; L M Nadler
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

2.  Agglutinin from Limulus polyphemus. Purification with formalinized horse erythrocytes as the affinity adsorbent.

Authors:  T P Nowak; S H Barondes
Journal:  Biochim Biophys Acta       Date:  1975-05-30

Review 3.  Immunoregulation in cryptococcosis.

Authors:  J W Murphy
Journal:  Immunol Ser       Date:  1989

Review 4.  Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction.

Authors:  N H Sigal; F J Dumont
Journal:  Annu Rev Immunol       Date:  1992       Impact factor: 28.527

5.  Regulation of cell-mediated immunity in cryptococcosis. I. Induction of specific afferent T suppressor cells by cryptococcal antigen.

Authors:  J W Murphy; J W Moorhead
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

6.  Transfer of immunity to cryptococcosis by T-enriched splenic lymphocytes from Cryptococcus neoformans-sensitized mice.

Authors:  T S Lim; J W Murphy
Journal:  Infect Immun       Date:  1980-10       Impact factor: 3.441

7.  Cryptococcal culture filtrate antigen for detection of delayed-type hypersensitivity in cryptococcosis.

Authors:  J W Murphy; N Pahlavan
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

8.  Host-etiological agent interactions in intranasally and intraperitoneally induced Cryptococcosis in mice.

Authors:  T S Lim; J W Murphy; L K Cauley
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

9.  Immunological unresponsiveness induced by cryptococcal capsular polysaccharide assayed by the hemolytic plaque technique.

Authors:  J W Murphy; G C Cozad
Journal:  Infect Immun       Date:  1972-06       Impact factor: 3.441

10.  Characterization of cellular infiltrates and cytokine production during the expression phase of the anticryptococcal delayed-type hypersensitivity response.

Authors:  K L Buchanan; J W Murphy
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

View more
  20 in total

1.  History of medical mycology in the united states.

Authors:  A Espinel-Ingroff
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

2.  Antigen-induced protective and nonprotective cell-mediated immune components against Cryptococcus neoformans.

Authors:  J W Murphy; F Schafer; A Casadevall; A Adesina
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

3.  Specific antibody to Cryptococcus neoformans alters human leukocyte cytokine synthesis and promotes T-cell proliferation.

Authors:  A Vecchiarelli; C Retini; C Monari; A Casadevall
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

4.  Differences in components at delayed-type hypersensitivity reaction sites in mice immunized with either a protective or a nonprotective immunogen of Cryptococcus neoformans.

Authors:  Kasie L Nichols; Sean K Bauman; Fredda B Schafer; Juneann W Murphy
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

5.  The gamma interferon receptor is required for the protective pulmonary inflammatory response to Cryptococcus neoformans.

Authors:  Gwo-Hsiao Chen; Roderick A McDonald; Jason C Wells; Gary B Huffnagle; Nicholas W Lukacs; Galen B Toews
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

6.  Decreased resistance to primary intravenous Cryptococcus neoformans infection in aged mice despite adequate resistance to intravenous rechallenge.

Authors:  K M Aguirre; G W Gibson; L L Johnson
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

Review 7.  Polysaccharide antigens of the capsule of Cryptococcus neoformans.

Authors:  R Cherniak; J B Sundstrom
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

8.  Cryptococcus neoformans infection in mice previously infected with LP-BM5 MuLV, the agent of murine AIDS (MAIDS).

Authors:  C Lacroix; F Chau; C Carbon; M Sinet; F Derouin
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

9.  Effects of tumor necrosis factor alpha on dendritic cell accumulation in lymph nodes draining the immunization site and the impact on the anticryptococcal cell-mediated immune response.

Authors:  Sean K Bauman; Gary B Huffnagle; Juneann W Murphy
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

10.  Phenotypic switching in Cryptococcus neoformans contributes to virulence by changing the immunological host response.

Authors:  Abraham Guerrero; Bettina C Fries
Journal:  Infect Immun       Date:  2008-06-30       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.